Sera Prognostics (SERA) Non-Current Debt (2020)
Sera Prognostics (SERA) posted Non-Current Debt of $348000.0 for Q4 2020.
Sera Prognostics (SERA) Non-Current Debt (2020) Analysis & Trends
Sera Prognostics' Non-Current Debt history runs 1 years deep, the most recent figure standing at $348000.0 for Q4 2020.
- Quarterly Non-Current Debt changed N/A year-over-year to $348000.0 in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $348000.0 (changed N/A YoY) and the FY2020 annual result came in at $348000.0, changed N/A from the prior year.
- Non-Current Debt was $348000.0 for Q4 2020 at Sera Prognostics.
- Across five years, Non-Current Debt topped out at $348000.0 in Q4 2020 and bottomed at $348000.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.67 Bn | 176.38 Bn | 6.27 Bn | 29.64 Bn |
| 2 | Stryker | 128.91 Bn | 126.03 Bn | 3.81 Bn | 14.22 Bn |
| 3 | Medtronic | 108.84 Bn | 99.62 Bn | 6.41 Bn | 26.17 Bn |
| 4 | Boston Scientific | 68.57 Bn | 67.12 Bn | 3.61 Bn | 10.99 Bn |
| 5 | Edwards Lifesciences | 48.68 Bn | 45.01 Bn | 1.29 Bn | 598.50 Mn |
| 6 | Dexcom | 28.42 Bn | 27.31 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.38 Bn | 26.09 Bn | 1.98 Bn | 10.13 Bn |
| 8 | Smith & Nephew | 26.94 Bn | 26.36 Bn | - | 3.18 Bn |
| 9 | Koninklijke Philips | 25.50 Bn | 22.38 Bn | 2.07 Bn | 8.07 Bn |
| 10 | Sera Prognostics | 107.05 Mn | 107.05 Mn | -28,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 348,000.00 |